News Oct 03 A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada Oct 03 New Best Practice Recommendations for SBMA Care in Canada Oct 02 Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting Oct 02 NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders Sep 24 2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open! Sep 02 Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients Sep 02 NMD4C Launches Clinical Summer School Sep 02 New BIND Study Highlights Financial Burden of Neuromuscular Disorders Aug 01 National Training Standards Approved for AFC in Neuromuscular Medicine 1 2 3 … 26 Next »
